HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial
NCT: NCT06719947 · RECRUITING
Brief Summary
Amyotrophic Lateral Sclerosis (ALS) is a nervous system disease that causes muscle weakness and rapidly progresses to the loss of mobility and functionality. Studies suggest that High-Definition Transcranial Direct Current Stimulation (HD-tDCS) is a technique for modulating motor cortical hyperexcitability. However, evidence on the use of HD-tDCS as a neuromodulator of the diaphragmatic motor cortex in people with ALS is inconclusive.
Frequently Asked Questions
What is HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial?
HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial is a clinical trial registered under NCT06719947. Current status: RECRUITING.
What is the status of NCT06719947?
The current status of NCT06719947 (HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial) is: RECRUITING.
When did HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial start?
HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial started on 2025-11-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.